English
Cibisatamab Biosimilar - Research Grade
Cibisatamab Biosimilar - Research Grade, Human IgG1-kappa/lambda with domain crossover, trivalent
Artikelnummer
ICH5041-10MG
Verpackungseinheit
10mg
Hersteller
Ichorbio
Verfügbarkeit:
wird geladen...
Preis wird geladen...
Target: CEA/CD3.
Specificity: Detects human CEACAM5. This non-therapeutic antibody uses the same sequence as the therapeutic antibody Cibisatamab.
Purification method: This monoclonal antibody was purified using multi-step affinity chromatography methods such as Protein A or G depending on the species and isotype.
Concentration: 5mg/ml.
Formulation: Sterile, preservative-free, solution in PBS. BSA and Azide free.
Purity: >95% by SDS-PAGE.
Endotoxin: ≤ 1.0 EU/mg as determined by the LAL method.
Use: Products are for research use only. Not for use in diagnostic or therapeutic procedures.
Specificity: Detects human CEACAM5. This non-therapeutic antibody uses the same sequence as the therapeutic antibody Cibisatamab.
Purification method: This monoclonal antibody was purified using multi-step affinity chromatography methods such as Protein A or G depending on the species and isotype.
Concentration: 5mg/ml.
Formulation: Sterile, preservative-free, solution in PBS. BSA and Azide free.
Purity: >95% by SDS-PAGE.
Endotoxin: ≤ 1.0 EU/mg as determined by the LAL method.
Use: Products are for research use only. Not for use in diagnostic or therapeutic procedures.
| Artikelnummer | ICH5041-10MG |
|---|---|
| Hersteller | Ichorbio |
| Hersteller Artikelnummer | ICH5041-10MG |
| Verpackungseinheit | 10mg |
| Mengeneinheit | STK |
| Reaktivität | Human |
| Klonalität | Monoclonal |
| Methode | Functional Assay |
| Isotyp | Human IgG1-kappa/lambda with domain crossover trivalent |
| Produktinformation (PDF) | Download |
| MSDS (PDF) | Download |
Verwandte Artikel
Markieren Sie die Artikel, um Sie dem Warenkorb hinzuzufügen oder
Immer für Sie da
Gernot Ensinger, M.Sc.
Laurent Haze
